|
1
|
Song F, He M, Li H, Qian B, Wei Q, Zhang
W, Chen K and Hao X: A cancer incidence survey in Tianjin: the
third largest city in China-between 1981 and 2000. Cancer Causes
Control. 19:443–450. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Jemal A, Siegel R, Ward E, Hao Y, Xu J and
Thun MJ: Cancer statistics, 2009. CA Cancer J Clin. 59:225–249.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Pike BL, Greiner TC, Wang X, Weisenburger
DD, Hsu YH, Renaud G, Wolfsberg TG, Kim M, Weisenberger DJ,
Siegmund KD, Ye W, Groshen S, Mehrian-Shai R, Delabie J, Chan WC,
Laird PW and Hacia JG: DNA methylation profiles in diffuse large
B-cell lymphoma and their relationship to gene expression status.
Leukemia. 22:1035–1043. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
García P, Manterola C, Araya JC, Villaseca
M, Guzman P, Sanhueza A, Thomas M, Alvarez H and Roa JC: Promoter
methylation profile in preneoplastic and neoplastic gallbladder
lesions. Mol Carcinog. 48:79–89. 2009. View
Article : Google Scholar : PubMed/NCBI
|
|
5
|
Kim TY, Jong HS, Song SH, Dimtchev A,
Jeong SJ, Lee JW, Kim TY, Kim NK, Jung M and Bang YJ:
Transcriptional silencing of the DLC-1 tumor suppressor gene by
epigenetic mechanism in gastric cancer cells. Oncogene.
22:3943–3951. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Wong CM, Lee JM, Ching YP, Jin DY and Ng
IO: Genetic and epigenetic alterations of DLC-1 gene in
hepatocellular carcinoma. Cancer Res. 63:7646–7651. 2003.PubMed/NCBI
|
|
7
|
Teramoto A, Tsukuda K, Yano M, Toyooka S,
Dote H, Doihara H and Shimizu N: Less frequent promoter
hypermethylation of DLC-1 gene in primary breast cancers. Oncol
Rep. 12:141–144. 2004.PubMed/NCBI
|
|
8
|
Song YF, Xu R, Zhang XH, Chen BB, Chen Q,
Chen YM and Xie Y: High-frequency promoter hypermethylation of the
deleted in liver cancer-1 gene in multiple myeloma. J Clin Pathol.
59:947–951. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Yuan BZ, Jefferson AM, Baldwin KT,
Thorgeirsson SS, Popescu NC and Reynolds SH: DLC-1 operates as a
tumor suppressor gene in human non-small cell lung carcinomas.
Oncogene. 23:1405–1411. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Xue W, Krasnitz A, Lucito R, Sordella R,
Vanaelst L, Cordon-Cardo C, Singer S, Kuehnel F, Wigler M, Powers
S, Zender L and Lowe SW: DLC1 is a chromosome 8p tumor suppressor
whose loss promotes hepatocellular carcinoma. Genes Dev.
22:1439–1444. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Dammann R, Strunnikova M, Schagdarsurengin
U, Rastetter M, Papritz M, Hattenhorst UE, Hofmann HS, Silber RE,
Burdach S and Hansen G: CpG island methylation and expression of
tumour-associated genes in lung carcinoma. Eur J Cancer.
41:1223–1236. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Mountain CF: Revisions in the
International System for Staging Lung Cancer. Chest. 111:1710–1717.
1997. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2−∆∆CT method. Methods. 25:402–408. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Castro M, Grau L, Puerta P, Gimenez L,
Venditti J, Quadrelli S and Sánchez-Carbayo M: Multiplexed
methylation profiles of tumor suppressor genes and clinical outcome
in lung cancer. J Transl Med. doi: 10.1186/1479-5876-8-86.
|
|
15
|
Seng TJ, Low JS, Li H, Cui Y, Goh HK, Wong
ML, Srivastava G, Sidransky D, Califano J, Steenbergen RD, Rha SY,
Tan J, Hsieh WS, Ambinder RF, Lin X, Chan AT and Tao Q: The major
8p22 tumor suppressor DLC1 is frequently silenced by methylation in
both endemic and sporadic nasopharyngeal, esophageal, and cervical
carcinomas, and inhibits tumor cell colony formation. Oncogene.
26:934–944. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Kikuchi S, Yamada D, Fukami T, Masuda M,
Sakurai-Yageta M, Williams YN, Maruyama T, Asamura H, Matsuno Y,
Onizuka M and Murakami Y: Promoter methylation of DAL-1/4.1B
predicts poor prognosis in non-small cell lung cancer. Clin Cancer
Res. 11:2954–2961. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Shopland DR, Eyre HJ and Pechacek TF:
Smoking-attributable cancer mortality in 1991: is lung cancer now
the leading cause of death among smokers in the United States? J
Natl Cancer Inst. 83:1142–1148. 1991. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Kim DH, Nelson HH, Wiencke JK, Zheng S,
Christiani DC, Wain JC, Mark EJ and Kelsey KT: p16(INK4a) and
histology-specific methylation of CpG islands by exposure to
tobacco smoke in non-small cell lung cancer. Cancer Res.
61:3419–3424. 2001.PubMed/NCBI
|
|
19
|
Jarmalaite S, Kannio A, Anttila S, Lazutka
JR and Husgafvel-Pursiainen K: Aberrant p16 promoter methylation in
smokers and former smokers with nonsmall cell lung cancer. Int J
Cancer. 106:913–918. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Kim DH, Kim JS, Ji YI, Shim YM, Kim H, Han
J and Park J: Hypermethylation of RASSF1A promoter is associated
with the age at starting smoking and a poor prognosis in primary
non-small cell lung cancer. Cancer Res. 63:3743–3746.
2003.PubMed/NCBI
|
|
21
|
Kikuchi S, Yamada D, Fukami T, Maruyama T,
Ito A, Asamura H, Matsuno Y, Onizuka M and Murakami Y:
Hypermethylation of the TSLC1/IGSF4 promoter is associated with
tobacco smoking and a poor prognosis in primary nonsmall cell lung
carcinoma. Cancer. 106:1751–1758. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Toyooka S, Maruyama R, Toyooka KO,
McLerran D, Feng Z, Fukuyama Y, Virmani AK, Zochbauer-Muller S,
Tsukuda K, Sugio K, Shimizu N, Shimizu K, Lee H, Chen CY, Fong KM,
Gilcrease M, Roth JA, Minna JD and Gazdar AF: Smoke exposure,
histologic type and geography-related differences in the
methylation profiles of non-small cell lung cancer. Int J Cancer.
103:153–160. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Peto R, Darby S, Deo H, Silcocks P,
Whitley E and Doll R: Smoking, smoking cessation, and lung cancer
in the UK since 1950: combination of national statistics with two
case-control studies. BMJ. 321:323–329. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Hussain SP and Harris CC: Inflammation and
cancer: an ancient link with novel potentials. Int J Cancer.
121:2373–2380. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Maekita T, Nakazawa K, Mihara M, Nakajima
T, Yanaoka K, Iguchi M, Arii K, Kaneda A, Tsukamoto T, Tatematsu M,
Tamura G, Saito D, Sugimura T, Ichinose M and Ushijima T: High
levels of aberrant DNA methylation in Helicobacter
pylori-infected gastric mucosae and its possible association
with gastric cancer risk. Clin Cancer Res. 12:989–995. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Belinsky SA, Nikula KJ, Baylin SB and Issa
JP: Increased cytosine DNA-methyltransferase activity is
target-cell-specific and an early event in lung cancer. Proc Natl
Acad Sci USA. 93:4045–4050. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Vertino PM, Yen RW, Gao J and Baylin SB:
De novo methylation of CpG island sequences in human fibroblasts
overexpressing DNA (cytosine-5-)-methyltransferase. Mol Cell Biol.
16:4555–4565. 1996. View Article : Google Scholar : PubMed/NCBI
|
